Tag: Small molecule inhibitors

According to the Crohn's & Colitis Foundation, hundreds of thousands of people in the U.S. live with Crohn's disease, and treatment options have significantly expanded in recent years. However, there is no single answer to the question, "What is the best drug to treat Crohn's disease?" as the optimal therapy is customized for each individual based on their specific condition.

Chronic activation of transforming growth factor-β (TGF-β) is a key driver of fibrosis in many organs, including the liver, lungs, and kidneys. This critical role has led to the development of various therapeutic strategies, making the exploration of what drugs are anti TGFB a significant area of research.

Transforming growth factor-beta (TGF-β) is a multifunctional cytokine implicated in numerous disease processes, including fibrosis and cancer. As a result, therapeutic strategies targeting this pathway have been developed, with a primary focus on understanding **what drugs inhibit TGF-beta** and how they can be used for patient benefit.